Altamira Therapeutics

Altamira Therapeutics is a biopharmaceutical company focused on developing innovative therapies for hearing protection, tinnitus management, and balance restoration. The company is a leader in addressing neurotologic disorders related to the inner ear, and it also engages in the development of therapeutics for unmet medical needs across various areas, including RNA therapeutics, allergies, and viral infections. One of its notable products, Bentrio, is a drug-free nasal spray designed to protect against airborne viruses and allergens. Altamira Therapeutics utilizes its proprietary OligoPhore / SemaPhore platform to create nanoparticle formulations that complex therapeutic RNAs with peptides, enabling effective delivery to tissues with leaky vasculature, which is characteristic of solid tumors and specific inflammatory conditions.